| Date | Title | Description |
| 19.05.2026 | Lansdowne Partners Ignites UK Innovation with New $150M VC Fund | Lansdowne Partners launched a pivotal new venture capital fund. It targets high-potential UK innovation. The fund secured $150 million in its initial close. It aims to bridge critical funding gaps. UK companies emerging from university rese... |
| 14.05.2026 | Lansdowne Partners: $150 Million First Close Announced For UK Innovation-Focused VC Fund | Lansdowne Partners has launched a venture capital fund focused on supporting high-potential UK companies emerging from the country’s university research base and startup ecosystem. The fund announced a first close of $150 million and is tar... |
| 14.05.2026 | Lansdowne Partners launches VC fund to scale UK innovation to global commercial success | Lansdowne Partners has launched a venture capital fund focused on backing high potential UK companies emerging from the country’s world class university research base and start up ecosystem. The fund announces a first close of $150 million ... |
| 10.05.2026 | Прочитал свой геном на кухне и превратил мазок щеки в 30 гигабаз данных ДНК | Перед вами перевод статьи о том, как прочитать свою ДНК дома. Автор разбирает бюджетный протокол MinION, типичные ошибки и мотивы эксперимента. Дальше слово автору.
Это руководство для инициативных и смелых энтузиастов, которые хотят узнать... |
| 18.11.2025 | The UK’s next big biotech? InvenireX secures £2M to commercialise its disease detection platform | Newcastle-based biotech InvenireX has secured £2 million in Seed funding to accelerate commercialisation of its DNA nanotechnology platform that can detect disease at the earliest biological stages.
The round is led by DSW Ventures, with pa... |
| 30.10.2025 | £55bn R&D Funding to Fuel UK Health & Clean Energy Innovation Funding boost to drive science & tech breakthroughs, create jobs, and boost economy | From airport security tech that screens luggage to life-saving medical innovations, the UK's leading inventors and innovators are set to receive a £55bn funding boost to advance their groundbreaking work. This new investment aims to support... |
| 23.10.2025 | African Countries Must Invest in Genomic Surveillance to Eliminate Rabies | Every year, rabies silently kills children across East Africa, even though it is one of the few infectious diseases that is 100% preventable. Globally, rabies causes approximately 59,000 deaths a year, mainly in Africa and Asia. In Kenya, 9... |
| 05.03.2025 | Nanopore Sequencing for RNA Vaccines and Therapeutics: Advancing Drug Development and Quality Control, Upcoming Webinar Hosted by Xtalks
USA - English | www.exothera.world
In this free webinar, learn how nanopore sequencing is transforming biopharmaceutical development with real-time genetic analysis. Attendees will gain insight into its expanding applications beyond traditional uses, inclu... |
| 10.01.2025 | Технологии секвенирования и геном человека | До чего дошел прогресс – до невиданных чудес… И одним из таких чудес, безусловно, является возможность читать «книгу жизни» посредством секвенирования нуклеиновых кислот, или, проще говоря, расшифровке их нуклеотидных последовательностей.
Д... |
| 13.12.2024 | The Scientist Announces Its 2024 Top 10 Innovations Winners | The Scientist Announces Its 2024 Top 10 Innovations Winners
The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the clinic and even the classroom.
WILMINGTON, Del., Dec. ... |
| 14.11.2024 | Shaping the future: Healthtech innovations | Healthtech companies are crucial in shaping the future of healthcare in Europe by providing innovative technologies that improve patient outcomes and healthcare system efficiency.
These solutions range from digital tools for health monitori... |
| 25.09.2024 | CariGenetics And One BioMed Strike Partnership to Advance Genomic Testing in the Caribbean - Decentralised Approach Serves the Needs of the Caribbean Community | HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ -- CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed's Xceler8 Platform across the Caribbean. Implementing this cutting-edge technology in the re... |
| 16.09.2024 | UK Spinouts Secure Over £1 Billion in H1 2024 | A report published today from Parkwalk, the UK’s biggest investor in university spinouts, has revealed that UK spinout investment is showing signs of recovery following a challenging year in 2023.
The report, Equity Investments Into Spinout... |
| 06.09.2024 | August 2024's top 10 European tech deals you need to know about | August was the slowest month YTD, with over €1.9 billion raised in some 203 deals. This figure represents a decrease of around 60 per cent compared to the previous month (in July European tech companies collected €5 billion).
The August slo... |
| 05.09.2024 | Temasek-backed biotech firm helps startups enter genomics space | Premium Content
It takes our newsroom weeks - if not months - to investigate and produce stories for our premium content. You can’t find them anywhere else.
Megan Cheah · 6 Sep 2024 · 6 min readTemasek-backed biotech firm helps startups ent... |
| 29.08.2024 | Dr Xand takes a visit to the BioResource laboratory | D-CYPHR ambassador checked out the exciting new technology used to decode the DNA provided by our volunteers.
Dr Xand explores the BioResource labs
We welcomed Dr Xand, one of our D-CYPHR ambassadors, to our laboratory to give him a tour of... |
| 13.05.2024 | Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK | BURLINGTON, Mass., May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further i... |
| 18.01.2024 | Straits Research Forecasts a Robust CAGR of 14.4% for Global Nanopore Technologies Market, Predicting a USD 597 Million Valuation by 2030 | - |
| 15.06.2023 | The Global Startup Ecosystem Report 2023 shows a year of challenges but also growth and resilience in Europe | The Global Startup Ecosystem Report 2023 (GSER 2023) launched today in Amsterdam.
Authored by Startup Genome, the report is informed by data on 3.5 million startups across 290+ global ecosystems. It provides new insights and deep knowledge ... |
| 12.06.2023 | Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing | The new platform is designed to enable the end-to-end analysis and clinical reporting of nanopore sequencing, empowering clinical labs, researchers and other users with an advanced, “one-click” solution
Oxford Nanopore Technologies plc (Oxf... |
| 25.08.2022 | Nanopore Technologies Market Forecasted to Cross Valuation of $680.87 Mn by 2030 | Nanopore Technologies Market Research
The global nanopore technologies market is projected to reach $6,80,872.4 thousand by 2030, registering a CAGR of 14.40% from 2021 to 2030. PORTLAND, OREGON, UNITED STATES, August 25, 2022 /EINPresswire... |
| 20.05.2022 | Oxford Nanopore Announces Tech Updates | Oxford Nanopore delivers technology update at annual London Calling conference: bringing together years of innovation to showcase one sensing platform for all biological analyses
OXFORD, UK / ACCESSWIRE / May 20, 2022 / At the annual London... |
| 10.05.2022 | Global Nanopore Sequencing Market valued at $200 million (2021), is set to witness a significant growth rate of 26% in the next 5 years | Medi-Tech Insights: Advantages of nanopore sequencing such as high throughput & ultra-long reads, technological advancements, increasing prevalence of infectious diseases, and rising investments in R&D are the key factors driving th... |
| 10.05.2022 | Global Nanopore Sequencing Market valued at $200 million (2021), is set to witness a significant growth rate of 26% in the next 5 years | Brussels, Belgium, May 10, 2022 (GLOBE NEWSWIRE) --
Description:
Nanopore Sequencing, a fourth-generation sequencing technology, in which single strands of DNA or RNA are passed through tiny protein channel called as nanopore. These nanopor... |
| 24.03.2022 | Oxford Nanopore Technologies PLC Announces Nanopore Sequencing Profiles TB: Find Evaluation | OXFORD, UK / ACCESSWIRE / March 24, 2022 / Oxford Nanopore announces positive evaluation of new method for rapid drug-resistant tuberculosis (DR-TB) profiling
On World Tuberculosis Day, Oxford Nanopore, in collaboration with Quadram Institu... |
| 23.03.2022 | Oxford Nanopore Releases Short Fragment Mode | Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA
Today, Short Fragment Mode will be integrated into the operating software that drives nanopore devices, allowing sequencing of fragm... |
| 04.02.2022 | Record-Breaking Rapid DNA Sequencing Promises Timely Diagnosis For Thousands Of Rare Disease Cases | For patients, often children, with rare diseases, getting a diagnosis is difficult and time-consuming. monkeybusinessimages/iStock via Getty Images
For children suffering from rare diseases, it usually takes years to receive a diagnosis. Th... |
| 04.02.2022 | Record-Breaking Rapid DNA Sequencing Promises Timely Diagnosis For Thousands Of Rare Disease Cases | For patients, often children, with rare diseases, getting a diagnosis is difficult and time-consuming. monkeybusinessimages/iStock via Getty Images |
| 02.12.2021 | IP : Oxford Nanopore Technologies plc - Announces technology updates at Nanopore Community Meeting | Highlights include release of new "Kit 12" and R10.4 flow cells for >Q20 (>99%) raw read and around Q30 (99.9%) Duplex sequencing accuracy, and the new PromethION P2 device, a palm-sized, high-throughput sequencer that deliv... |
| 28.09.2021 | Oxford Nanopore valued at nearly $5 bln after setting IPO price | Sept 28 (Reuters) - Oxford Nanopore has priced its London initial public offering at 425 pence per share, a bookrunner said on Tuesday, giving it an expected market valuation of around 3.6 billion pounds ($4.92 billion) including its use o... |
| 23.09.2021 | Oxford Nanopore prices IPO to give valuation of up to $4.77 billion - bookrunner | The offer will total 523 million pounds ($713.16 million) to 547 million pounds, giving the life sciences company an implied market capitalisation of 3 billion to 3.5 billion pounds , the bookrunner said.
Earlier this month, U.S. tech compa... |
| 16.09.2021 | Oracle and Oxford Nanopore Team Up to Improve Healthcare and Speed Discovery of New Medical Breakthroughs | Advances in DNA/RNA sequencing promise to revolutionize how medical communities identify, detect, and treat diseases and manage public health threats. To make this technology more accessible and increase its impact, Oracle has teamed up wit... |
| 16.09.2021 | Oxford Nanopore to Raise GBP300 Million in London IPO -- Update | By Jaime Llinares Taboada
Oxford Nanopore Technologies Ltd. said Thursday that it intends to raise around 300 million pounds ($415.3 million) at its initial public offering in London, half of which will be provided by Texas-based software p... |
| 16.09.2021 | Oxford Nanopore to Raise GBP300 Million in London IPO | By Jaime Llinares Taboada
Oxford Nanopore Technologies Ltd. said Thursday that it intends to raise around 300 million pounds ($415.3 million) at its initial public offering in London, half of which will be provided by Texas-based software p... |
| 09.09.2021 | Oxford Nanopore announces London IPO after hitting $3.3 billion valuation | The life sciences company is planning a free float of at least 25% of its shares in the initial public offering (IPO) and said it was aiming to reduce its losses to breakeven in the next five years.
A successful deal would be a major coup f... |
| 09.09.2021 | IP : Oxford Nanopore bets on London with IPO, to top up its £2.5bn valuation | Oxford Nanopore, who specialises in DNA sequencing technology crucial for Covid-19 testing, is set to float in London, which could secure a valuation north of £2.5bn.
The biotech firm is the latest technology heavyweight to confirm its inte... |
| 09.09.2021 | Oxford Nanopore bets on London with IPO, to top up its £2.5bn valuation | Oxford Nanopore, whose DNA technology has been used to sequence global variants, is set to float in London, in a listing that could secure a valuation north of £2.5bn. |
| 01.09.2021 | Oxford Nanopore to launch $3.4 billion London IPO in coming weeks - sources | By Abhinav Ramnarayan
LONDON (Reuters) - Oxford Nanopore, a provider of rapid COVID-19 tests to the UK’s national health service, is working with banks to launch an initial public offering (IPO) on the London Stock Exchange in the coming we... |
| 01.09.2021 | Oxford Nanopore to launch $3.4 billion London IPO in coming weeks - sources | The company aims to build on the 2.48 billion pounds ($3.42 billion) valuation achieved in a funding round in May, two sources familiar with the matter said.
The Oxford-based life sciences firm, which counts IP Group and Singapore's Temasek... |
| 07.07.2021 | NVIDIA launches UK’s most powerful supercomputer for research in AI and healthcare | NVIDIA launches UK’s most powerful supercomputer for research in AI and healthcare
07-07-2021
NVIDIA has officially launched Cambridge-1, the UK's most powerful supercomputer, which will enable top scientists and healthcare experts to use t... |
| 07.07.2021 | NVIDIA launches UK’s most powerful supercomputer for research in AI and healthcare | NVIDIA has officially launched Cambridge-1, the UK's most powerful supercomputer, which will enable top scientists and healthcare experts to use the powerful combination of AI and simulation to accelerate the digital biology revolution and ... |
| 07.07.2021 | NVIDIA Launches UK's Most Powerful Supercomputer, for Research in AI and Healthcare | LONDON, July 06, 2021 (GLOBE NEWSWIRE) -- NVIDIA today officially launched Cambridge-1, the United Kingdom’s most powerful supercomputer, which will enable top scientists and healthcare experts to use the powerful combination of AI and simu... |
| 05.05.2021 | Oxford Nanopore raises $271M for sequencing tools amid IPO plans | After closing three separate funding rounds throughout 2020 that, all together, totaled more than $300 million, Oxford Nanopore Technologies is well on track to make 2021 even bigger.
The new financing brings Oxford Nanopore’s total funding... |
| 05.05.2021 | UK's Oxford Nanopore banks £195M ahead of IPO | DNA sequencing startup Oxford Nanopore has raised £195 million. New investors Temasek, Wellington Management, M&G Investments and Nikon participated in the round, alongside existing backers. The funding comes ahead of a planned listing ... |
| 05.05.2021 | Oxford Nanopore raises $271M for sequencing tools amid IPO plans | After closing three separate funding rounds throughout 2020 that, all together, totaled more than $300 million, Oxford Nanopore Technologies is well on track to make 2021 even bigger.
Just a few weeks after announcing its plans to go public... |
| 04.05.2021 | Oxford Nanopore Technologies Limited announced that it has received £195 million in funding from M&G Investment Management Limited, Nikon Corporation, Temasek Holdings Limited, Wellington Manageme... | Oxford Nanopore Technologies Limited announced that it has received £195 million in equity round of funding on May 4, 2021. The transaction included participation from new investors M&G Investment Management Limited, Nikon Corporation (... |
| 04.05.2021 | M&G PLC
M&G : invests £35 million in Oxford Nanopore Technologies | 4 May 2021
M&G invests £35 million in Oxford Nanopore Technologies
M&G plc today announces that it has participated in a private transaction totalling £195 million, investing £35 million in Oxford Nanopore Technologies (Oxford Nanop... |
| 04.05.2021 | IP GROUP PLC
Oxford Nanopore valued at $3.4 billion ahead of IPO | Singapore's Temasek, Wellington Management, M&G Investments and Nikon put 125 million pounds into the life sciences company, according to IP Group, with M&G saying it had invested 35 million pounds. Existing investors including IP G... |
| 04.05.2021 | Oxford Nanopore raises £195m ahead of London listing | Oxford Nanopore has raised £195m in fresh funding ahead of its planned IPO in London later this year, it said this morning. |
| 30.03.2021 | British Biotech Oxford Nanopore Prepares for $3 Billion London IPO | Oxford Nanopore said on Tuesday that it has started preparing for a potential initial public offering, which could value the U.K.-based biotech revolutionizing real-time genetic sequencing at more than £2 billion ($3.17 billion).
The Oxford... |
| 30.03.2021 | Forma sees data 'supporting' sickle cell therapy dosing levels; LianBio teams with Tarsus for eye irritation in China | Looking to make a splash in sickle cell, Forma Therapeutics presented new data they hope can improve their shot at an eventual FDA OK.
As part of an ongoing Phase I study, Forma said its FT-4202 program showed enough hemog... |
| 12.02.2021 | Britain’s Minority Businesses Punch Above Their Weight But They Need Help | Ellenor McIntosh, co-founder of TwipesTwipes |
| 11.09.2020 | Real-time gene sequencing can help control — and may someday prevent — pandemics | As the novel coronavirus continues to infect people around the world, scientists have scrambled to understand its origins and evolution and learn how and where it is spreading. As a developer of gene-sequencing technology, I look to the vir... |
| 22.04.2020 | How the Covid-19 pandemic has put the UK healthtech sector centre stage | The UK’s healthtech sector has rallied its world-class talent and skills to help in the fight against Covid-19. Startups and scaleups have found themselves working side by side with large-scale, global tech companies towards the common goal... |
| 03.01.2020 | Offering much needed relief for Woodford-associated funds, sequencing unicorn Oxford Nanopore raises $105.9M in new cash | Investors in Oxford Nanopore Technologies — including Neil Woodford’s former fund — has managed to recoup some cash as the gene sequencing device maker closes its latest round and, in the process, boosts its unicorn valua... |
| 23.10.2018 | Edinburgh Tech Scene Helps Drive UK Success | The UK has created more tech unicorns (companies valued at $1 billion+) than Germany, France, Sweden and the Netherlands combined, according to new analysis from Dealroom.co.
The venture capital analytics company reports that the UK’s leadi... |
| 21.03.2018 | Oxford Nanopore raises $140M to set up sequencing showdown with Illumina | Oxford Nanopore Technologies (ONT) has tapped a global syndicate of investors for $140 million to fuel its attempts to upend the genome sequencing market. The financing equips ONT to scale up its operation as it moves deeper into territory ... |
| 21.03.2018 | Hostplus invests $27.5 million in UK-based DNA sequencing startup Oxford Nanopore Technologies | Hostplus Super, an industry super fund for the hospitality sector, has invested $27.5 million into Oxford Nanopore Technologies, joining investors including Singapore’s and China Construction Bank International in the £100M ($182 million) r... |
| 20.03.2018 | Term Sheet — Tuesday, March 20 | FERRO OUT
Good morning, Term Sheet readers. Lots of news today.
Paid Content You can't secure what you can't see From ExtraHop
Some people on Twitter were skeptical about the sudden retirement, asking “What’s the rest of the story?”
Hours l... |
| 20.03.2018 | Singapore’s GIC backs DNA sequencing firm Oxford Nanopore’s $140m funding round | Premium
Singapore’s sovereign wealth fund GIC has participated in the $140-million funding round of Oxford Nanopore Technologies Ltd, the maker of the portable real-time DNA/RNA sequencer MinION, according to a statement.
Continue reading t... |
| 20.03.2018 | Oxford Nanopore Technologies Raises £100M in Funding | Oxford Nanopore Technologies Ltd, an Oxford, UK-based developer of a portable real-time DNA/RNA sequencer, raised £100M ($140M) in new funding.
Backers included GIC (Singapore), China Construction Bank International (CCBI, China), Hostplus ... |
| 12.12.2016 | Oxford Nanopore Technologies Raises £100M in Funding | Oxford Nanopore Technologies Ltd, an Oxford, UK-based technology company that has designed and sells a portable DNA/RNA sequencer, raised £100m (approx. $126m) in funding.
The round, which brought total funding to £351m, was led by new inve... |
| 20.04.2016 | Innovation in genomics and the future of medtech | Dr. Lavinia Ionita Contributor
Dr. Lavinia Ionita is the CEO and a co-founder of Omixy.
The field of medicine is in the process of being profoundly transformed by new technologies; much of this transformation comes from exciting advances in... |
| 05.11.2015 | You Can Sequence Your Own DNA Using The MinION Handheld Device | Christian de Looper, Tech Times 05 November 2015, 06:11 pm
Being able to sequence DNA on the fly used to be a thing of sci-fi films, but a working device has finally brought the technology into the real world.
The device is called MinION, a... |
| 16.10.2015 | Oxford Nanopore’s handheld sequencer gets rave reviews | While the device won’t do whole genome sequencing, or conduct them with the same acuity as, say, one of Illumina’s X Tens, it can rapidly identify bacterial and viral strains, and determine genetic variants in portions of DNA. Although this... |
| 21.07.2015 | Daily funding roundup - July 21, 2015 | Bright.md raises $3.5M; Medallia bagged $150M; BrightBytes landed $33M
Bright.md, which makes software that enables communication between doctors and patients, closed a $3.5 million Series A funding round. Oregon Angel Fund led the round, w... |
| 21.07.2015 | Oxford Nanopore Technologies Raises £70M in Funding | Oxford Nanopore Technologies Ltd, an Oxford, UK-based technology company that has designed and produced a DNA sequencer based on nanopore sensing, raised £70m ($109m) in funding.
Both new and existing investors in the UK, US and mainland Eu... |
| 14.05.2015 | $474M Fund Will Support Oxford University Spinouts | A new £300 million U.K. fund has been set up to support high tech startups looking to spin out of the University of Oxford. The fund is being raised by Oxford Sciences Innovation (OSI), a newly formed company that is working in partnership ... |
| 14.05.2015 | $475M fund will help commercialize Oxford University’s spinout tech firms | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The University of Oxford has produced some of Bri... |
| 14.05.2015 | $475M fund will help commercialize Oxford University’s spinout tech firms | The University of Oxford has produced some of Britain’s greatest minds, and to help in its quest to stay at the forefront of technological innovation, the institution’s commercial arm has set up a £300 million ($475 million) fund to develop... |
| 12.08.2014 | Oxford Nanopore Technologies Raises £35M | Oxford Nanopore Technologies Ltd, an Oxford, UK-based developer of nanopore-based electronic molecular analysis systems, raised £35m ($59m) in funding.
Both new and existing investors in the UK, US and mainland Europe subscribed to the fund... |
| 09.10.2013 | Oxford Nanopore Technologies Raises £40M in Funding | Oxford Nanopore Technologies Ltd, a UK-based company specializing in nanopore-based electronic molecular analysis systems, has raised £40m in funding.
Backers included new and existing investors in the US, UK and mainland Europe. New invest... |
| 15.11.2012 | The $1,000 genome question has turned into, “How can we understand this data?” | Life Technologies and Harvard Medical School professor George Church may be the only ones who have officially thrown their hats in the ring for the $10 million Archon Genomics X Prize, but many others have made ambitious promises in the que... |
| 29.03.2012 | The Cloud Will Cure Cancer | Editor’s note: Mark Kaganovich is founder of SolveBio and a doctoral candidate in genetics at Stanford University. Follow him on Twitter @markkaganovich.
Much ink has been spilled on the huge leaps in communications, social networking, and ... |
| 28.04.2011 | Bankrupt ReGen gets another cash infusion through investor | Funding roundup | Bankrupt ReGen Biologics Inc. (OTC:RGBO) took out a loan from a company affiliated with one of its investors. The new debt represents Regen’s second financing deal with the company since filing for Chapter 11 bankruptcy two weeks ago.
Sport... |
| 26.04.2011 | Oxford Nanopore Technologies Raises £25M | Oxford Nanopore Technologies Ltd., an Oxford, UK-based developer of nanopore technology for the direct, electronic analysis of single molecules, has raised £25m (approximately $41m) in new funding.
Backers include Lansdowne Partners, IP Gro... |
| 01.02.2010 | UK, Oxford Nanopore Technologies Raises £17.4M | Oxford Nanopore Technologies Ltd., an Oxford, UK-based developer of a technology platform for direct, electrical detection and analysis of single molecules, has raised £17.4m (approximately $28m) in new funding.
The round was funded by exis... |
| - | Oxford Nanopore’s handheld sequencer gets rave reviews | Oxford Nanopore‘s handheld MinION sequencing device is receiving rave reviews from the scientists that have tested it.
The mini-sequencer allows users to sequence DNA remotely – and could help track disease outbreaks, provide food security ... |
| - | The $1,000 genome question has turned into, “How can we understand this data?” | His most recent book is called The $1,000 Genome, but Kevin Davies says that the $100 genome isn’t out of reach in the move toward personalized medicine.
The author and editor-in-chief of Bio-IT World laid out a brief history of whole genom... |
